AzarGen Biotechnologies
OperatingAzarGen is a biotech company focused on developing human therapeutic proteins using advanced genetic engineering & synthetic biology
- Biotechnology
- Stellenbosch, South Africa
- Series B
- Founded 2009
- azargen.com ↗
- Total raised
- $3.1M
- disclosed
- Last round
- $3.1M
- Series B
- Rounds
- 1
- since 2009
- Employees
- 1-10
AzarGen Biotechnologies founders and team
Mauritz Venter is the CEO.
- Employees
- 1-10
- Leadership
- 2
- C-level, heads & VPs
AzarGen Biotechnologies executives2
Frequently asked about AzarGen Biotechnologies
- Who is the CEO of AzarGen Biotechnologies?
- Mauritz Venter is AzarGen Biotechnologies' CEO.
Profile updated Source: SLA Startup IndexHow we count →
